| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 350.00K | — |
| Operating expense | — | — |
| Net income | -83.71M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, RLAY returned +426.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +129.8% |
| 1 year | +426.8% |
| 5 years | -39.3% |
| All-time high | $53.31 (Nov 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in RLAY would be worth today ›No. Relay Therapeutics, Inc. has not paid a dividend in the past 12 months.
Relay Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol RLAY.
Relay Therapeutics, Inc. is part of the Healthcare sector.
Relay Therapeutics, Inc. has a market cap of 4.26B USD, based on the latest quote.
Relay Therapeutics, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
